Home Mechanical Ventilation (HMV) UK Meeting 2024

At Philips, we look beyond technology to the experiences of consumers, patients, providers and caregivers. We unlock insights leading to innovative solutions that help deliver improved patient experience, better health outcomes, improved staff experience, and lower cost of care. With leading research, design and innovation capabilities, we partner with our customers to transform the delivery of healthcare.

Breas Medical is a global company headquartered in Sweden, with over 30 years of expertise in ventilation, airway clearance, and sleep solutions. We are passionate experts dedicated to respiratory care, with an unwavering focus on the patient and the caregiver, delivering high-quality and reliable products. We aim to respond to changing clinical needs with agility, and while growing globally, we take customer care personally. Our solutions cover a broad range of devices, consumables, service solutions, educational & training programs, and comprehensive connectivity capabilities to improve the quality of life of patients, from hospital to home. Our mission is to improve the quality of life and care of respiratory patients around the world through a personal commitment to innovation, quality, and customer focus. Our vision is to become the first choice of healthcare providers and respiratory patients around the world through an ecosystem of innovative devices, services, software solutions, and customer care. Be sure to come and see our device range at HMV-UK, including: • Vivo 1 & 2 (Bi-level) • Vivo 3 and Nippy 4 (Mid-Range NIV) • Nippy 4+ (Life support ventilator for dependent patients) • Clearway 2 (Mechanical Insufflation-Exsufflation device for Airway Clearance)

Founded in 1935, we are now a world leading provider of technologically advanced point-of-care solutions, designed to simplify and automate all phases of acute care testing. Since launching the world’s first commercially available blood gas analyser in 1954, we continue to build on a legacy of innovation. Our mission: To help caregivers make diagnostic decisions that save lives. Our vision: Improving global healthcare with reliable, fast and easy patient diagnoses. Our portfolio: • Blood gas analysis on the ABL90 FLEX PLUS, a compact analyser that measures 19 key parameters (including creatinine and urea) via a single 65µL blood sample, in 35 seconds. • Immunoassay testing on the AQT90 FLEX, a benchtop analyser that measures; Cardiac, Coagulation, Infection, Inflammation and Pregnancy biomarkers via whole blood samples between 11-21 minutes, using a standard EDTA or Lithium Heparin vacutainer. • Vendor neutral connectivity via our AQURE data management system, helping with the governance and compliance requirements for point-of-care testing. • Blood gas sampler solutions in our safePICO and safeClinitube range, helping minimise pre-analytical errors in both syringe and capillary sampling. • For respiratory and neonatal medicine, transcutaneous carbon dioxide, and oxygen/oxygen saturation monitoring on the TCM5, a table-top monitor providing non-invasive, continuous information on a patient’s oxygenation and ventilation status. By providing fast and accurate results, healthcare professionals can make immediate, well-informed decisions enabling them to improve patient care and optimise patient flow. Email: [email protected] Website: www.radiometer.co.uk and ww.acutecaretesting.org

ResMed is a global pioneer in innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our ecosystem of cloud-connected medical devices help transform care for people with sleep apnoea, and other chronic diseases, while our digital health technologies drive new efficiencies in population health management. The healthcare environment in the UK is evolving rapidly. As the population ages, chronic diseases are becoming more common. As a result, there is increased pressure on the healthcare industry and providers. ResMed is stepping up to the challenge and creating a future where healthcare is faster, more effective and more efficient. We’re connecting data, connecting patients and connecting healthcare to facilitate care and improve the therapy experience. With more than 20.5 million cloud-connectable devices worldwide providing medical sleep and respiratory data, we are continuously working to reduce the impact of chronic disease and lower costs for consumers and healthcare systems. Telemonitoring is particularly appropriate for the management of chronic, progressive conditions that require regular clinical follow-up, such as neuromuscular disease and chronic obstructive pulmonary disease (COPD). AirView, our cloud-based patient monitoring system, connects to ResMed’s sleep, ventilation and high-flow therapy (HFT) devices so you can manage and support patients on these different treatments via the same platform. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice.

At Sanofi, we chase the miracles of science to improve people’s lives. Sanofi’s Rare Disease franchise focuses on lysosomal storage disorders (LSDs) including Pompe, Fabry and Gaucher disease and other rare conditions such as acquired thrombotic thrombocytopenic purpura (aTTP). Patients with rare diseases can endure a long journey involving numerous tests, misdiagnoses, and visits to different departments. Focusing on uncommon and underserved medical conditions, Sanofi’s Rare Disease franchise empowers the lives of people with rare diseases with health care options that are highly specialised and can be transformative.

Air Liquide Healthcare: Is a leading healthcare provider to patients with long-term respiratory and diabetes conditions, having treated over 25,000 patients over 15 years in the UK alone. Following a long history of providing oxygen services to patients in the hospital and at home we are launching our range of respiratory devices and consumables used extensively globally. Air Liquide has a focus on advanced home mechanical ventilation, secretion management, NIV consumables and masks and a full CPAP therapy and diagnostic offering. We aim to provide our new devices in a variety of ways and services. Managed service, rental, patient support, and remote data management are all ways we can help your respiratory service utilising our team of respiratory therapy technicians and nurses. For further information: [email protected] www.https://www.airliquidehealthcare.co.uk/ventilation-service/our-solutions.

Sentec transcutaneous technology offers accurate, continuous, and noninvasive CO2 values for proactive management of patients both on and off respiratory support of all types while overcoming the limits of SPO2, ABs, and end-tidal monitoring techniques. Transcutaneous monitoring has been shown to inform timely optimization of NIV and support assessment of extubation readiness while reducing the need for invasive blood draws.